XML 57 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue and Accounts Receivable Credit Concentration - Summary of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation Of Revenue [Line Items]        
Revenues $ 18,151 $ 13,491 $ 50,894 $ 34,419
Diagnostic Tests        
Disaggregation Of Revenue [Line Items]        
Revenues 17,168 12,301 47,503 32,395
Biopharma Services and Other        
Disaggregation Of Revenue [Line Items]        
Revenues $ 983 $ 1,190 $ 3,391 $ 2,024